Vestor Capital LLC Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Vestor Capital LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 16,099 shares of the healthcare conglomerate’s stock after acquiring an additional 37 shares during the period. Vestor Capital LLC’s holdings in UnitedHealth Group were worth $8,144,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group during the third quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.3 %

UnitedHealth Group stock opened at $517.72 on Friday. The firm’s 50-day moving average is $510.19 and its 200-day moving average is $547.47. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market cap of $473.57 billion, a P/E ratio of 33.40, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 0.33% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages recently commented on UNH. Oppenheimer upped their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. KeyCorp reissued an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.